448 related articles for article (PubMed ID: 8118811)
21. CEA-specificity of CEA-reactive monoclonal antibodies. Immunochemical and immunocytochemical studies.
Verstijnen CP; Arends JW; Moerkerk PT; Warnaar S; Hilgers J; Bosman FT
Anticancer Res; 1986; 6(1):97-104. PubMed ID: 2420267
[TBL] [Abstract][Full Text] [Related]
22. [CEA and related antigens as possible new tumor markers].
Matsuoka Y
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1754-63. PubMed ID: 6688338
[TBL] [Abstract][Full Text] [Related]
23. Selection of a monoclonal antibody reactive with a high-molecular-weight glycoprotein circulating in the body fluid of gastrointestinal cancer patients.
Sakurai Y; Hirohashi S; Shimosato Y; Kodaira S; Abe O
Cancer Res; 1988 Jul; 48(14):4053-8. PubMed ID: 2454734
[TBL] [Abstract][Full Text] [Related]
24. [Biliary carcinoembryonic antigen, non-specific cross-reacting antigen and biliary glycoprotein--their analysis and clinical aspects].
Yano Y
Nihon Geka Gakkai Zasshi; 1986 Nov; 87(11):1432-42. PubMed ID: 3537682
[TBL] [Abstract][Full Text] [Related]
25. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells.
Hampton R; Walker M; Marshall J; Juhl H
Oncogene; 2002 Nov; 21(51):7817-23. PubMed ID: 12420218
[TBL] [Abstract][Full Text] [Related]
28. Immunochemical differences among carcinoembryonic antigen in tumor tissues and related antigens in meconium and adult feces.
Matsuoka Y; Kuroki M; Koga Y; Kuriyama H; Mori T; Kosaki G
Cancer Res; 1982 May; 42(5):2012-8. PubMed ID: 6175402
[TBL] [Abstract][Full Text] [Related]
29. Production of monoclonal antibodies against the non-specific cross-reacting antigen (NCA).
Chavanel G; Frenoy N; Escribano MJ; Burtin P
Oncodev Biol Med; 1983; 4(3):209-17. PubMed ID: 6402767
[TBL] [Abstract][Full Text] [Related]
30. The use of human monoclonal antibody to detect serum antigen in patients with breast cancer.
Strelkauskas AJ; Aldenderfer PH; Warner GA
Anticancer Res; 1989; 9(6):1863-8. PubMed ID: 2627133
[TBL] [Abstract][Full Text] [Related]
31. Radical differences in functions of closely related members of the human carcinoembryonic antigen gene family.
Rojas M; DeMarte L; Screaton RA; Stanners CP
Cell Growth Differ; 1996 May; 7(5):655-62. PubMed ID: 8732675
[TBL] [Abstract][Full Text] [Related]
32. Preparation and characterization of two human carcinoembryonic antigen family proteins of neutrophils, CD66b and c, in silkworm larvae.
Yamanaka T; Kuroki M; Kinugasa T; Matsuo Y; Matsuoka Y
Protein Expr Purif; 1996 Jun; 7(4):438-46. PubMed ID: 8776764
[TBL] [Abstract][Full Text] [Related]
33. XAGE-1a and XAGE-1d are potential biomarkers of lung squamous cell carcinoma.
Ha JS; Sung HY; Kim SY; Lim HM; Kim HK; Park SS
Clin Chim Acta; 2012 Aug; 413(15-16):1226-31. PubMed ID: 22515959
[TBL] [Abstract][Full Text] [Related]
34. [Establishment of a method to detect multiple antennae carcinoembryonic antigen (MA-CEA) and MA-CEA level in the sera of patients with malignant tumors].
Zhang LJ; Liu SL; Xu SJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):734-6. PubMed ID: 15555448
[TBL] [Abstract][Full Text] [Related]
35. Immunocytochemical evaluation of primary human esophageal carcinomas and their xenografts for keratin, beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Valerio MG; Harris CC; Trump BF
Cancer Res; 1986 Nov; 46(11):5730-7. PubMed ID: 2428482
[TBL] [Abstract][Full Text] [Related]
36. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
[TBL] [Abstract][Full Text] [Related]
37. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
[TBL] [Abstract][Full Text] [Related]
38. Antigenic heterogeneity of human lung cancers.
Harłozińska A; Richter R; Albert Z; Zawadzka H
J Natl Cancer Inst; 1983 Mar; 70(3):427-33. PubMed ID: 6300497
[TBL] [Abstract][Full Text] [Related]
39. CEA and NCA levels in peripheral and tumour venous blood of patients with gastric and colonic carcinomas estimated by RIA and EIA methods.
Harłozińska A; Rachel F; Gawlikowski W; Richter R; Kołodziej J
Eur J Surg Oncol; 1991 Feb; 17(1):59-64. PubMed ID: 1995360
[TBL] [Abstract][Full Text] [Related]
40. Utility of slot-blot-ELISA as a new, fast, and sensitive immunoassay for detection of carcinoembryonic antigen in the urine samples of patients with various gastrointestinal malignancies.
El-Masry S; El-Sayed IH; Lotfy M; Mahmoud L; El-Naggar M
J Immunoassay Immunochem; 2007; 28(2):91-105. PubMed ID: 17424828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
